Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19797 | 489 | 42.9 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
207 | 3 | MULTIPLE SCLEROSIS//MYASTHENIA GRAVIS//MULTIPLE SCLEROSIS JOURNAL | 52279 |
58 | 2 | MULTIPLE SCLEROSIS//MULTIPLE SCLEROSIS JOURNAL//NEUROMYELITIS OPTICA | 29459 |
19797 | 1 | UCLA MULTIPLE SCLEROSIS PROGRAM//POSTPARTUM ACTIVATION//MULTIPLE SCLEROSIS | 489 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | UCLA MULTIPLE SCLEROSIS PROGRAM | address | 249774 | 1% | 100% | 4 |
2 | POSTPARTUM ACTIVATION | authKW | 187330 | 1% | 100% | 3 |
3 | MULTIPLE SCLEROSIS | authKW | 165629 | 48% | 1% | 234 |
4 | MULTIPLE SCLEROSIS PROGRAM | address | 162332 | 3% | 20% | 13 |
5 | LEUVEN FERTIL | address | 124887 | 0% | 100% | 2 |
6 | PATIENT POWERED RESEARCH NETWORKS | authKW | 124887 | 0% | 100% | 2 |
7 | RELAPSING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | authKW | 124887 | 0% | 100% | 2 |
8 | POSTPARTUM RELAPSE | authKW | 124883 | 1% | 50% | 4 |
9 | NEUROIMMUNOL RD 31 | address | 104066 | 1% | 33% | 5 |
10 | COUSINS | address | 93662 | 1% | 50% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 5782 | 47% | 0% | 231 |
2 | Neurosciences | 1831 | 36% | 0% | 178 |
3 | Immunology | 517 | 17% | 0% | 83 |
4 | Obstetrics & Gynecology | 167 | 6% | 0% | 31 |
5 | Anesthesiology | 61 | 2% | 0% | 12 |
6 | Endocrinology & Metabolism | 44 | 5% | 0% | 24 |
7 | Psychiatry | 28 | 4% | 0% | 19 |
8 | Reproductive Biology | 21 | 2% | 0% | 8 |
9 | Nursing | 18 | 1% | 0% | 7 |
10 | Geriatrics & Gerontology | 9 | 1% | 0% | 5 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UCLA MULTIPLE SCLEROSIS PROGRAM | 249774 | 1% | 100% | 4 |
2 | MULTIPLE SCLEROSIS PROGRAM | 162332 | 3% | 20% | 13 |
3 | LEUVEN FERTIL | 124887 | 0% | 100% | 2 |
4 | NEUROIMMUNOL RD 31 | 104066 | 1% | 33% | 5 |
5 | COUSINS | 93662 | 1% | 50% | 3 |
6 | FDN EUGENE DEVIC EDMUS SCLEROSE PLAQUES | 83257 | 0% | 67% | 2 |
7 | PAEDIAT YOUTH MED | 83257 | 0% | 67% | 2 |
8 | PARTNERS MULTIPLE SCLEROSIS | 71223 | 2% | 13% | 9 |
9 | AUTOIMMUNE NEUROL MULTIPLE SCLEROSIS | 62443 | 0% | 100% | 1 |
10 | BIOCHEM CHILD HLTH ANIM SCI | 62443 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MULTIPLE SCLEROSIS JOURNAL | 44835 | 8% | 2% | 41 |
2 | THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS | 10194 | 1% | 3% | 5 |
3 | MULTIPLE SCLEROSIS AND RELATED DISORDERS | 4209 | 1% | 1% | 5 |
4 | JOURNAL OF NEUROIMMUNOLOGY | 4070 | 4% | 0% | 21 |
5 | MULTIPLE SCLEROSIS | 2788 | 1% | 1% | 5 |
6 | JOURNAL OF THE NEUROLOGICAL SCIENCES | 2452 | 4% | 0% | 20 |
7 | JOURNAL OF NEUROLOGY | 1997 | 3% | 0% | 14 |
8 | BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY | 1925 | 1% | 1% | 4 |
9 | ACTA NEUROLOGICA SCANDINAVICA | 1230 | 2% | 0% | 11 |
10 | ARCHIVES OF NEUROLOGY | 1130 | 2% | 0% | 11 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | COYLE, PK , (2016) MANAGEMENT OF WOMEN WITH MULTIPLE SCLEROSIS THROUGH PREGNANCY AND AFTER CHILDBIRTH.THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. VOL. 9. ISSUE 3. P. 198 -210 | 65 | 77% | 4 |
2 | BOVE, R , (2016) WOMEN'S ISSUES IN MULTIPLE SCLEROSIS.SEMINARS IN NEUROLOGY. VOL. 36. ISSUE 2. P. 154 -162 | 77 | 64% | 1 |
3 | BOVE, R , ALWAN, S , FRIEDMAN, JM , HELLWIG, K , HOUTCHENS, M , KOREN, G , LU, E , MCELRATH, TF , SMYTH, P , TREMLETT, H , ET AL (2014) MANAGEMENT OF MULTIPLE SCLEROSIS DURING PREGNANCY AND THE REPRODUCTIVE YEARS A SYSTEMATIC REVIEW.OBSTETRICS AND GYNECOLOGY. VOL. 124. ISSUE 6. P. 1157 -1168 | 81 | 62% | 6 |
4 | GHEZZI, A , ANNOVAZZI, P , PORTACCIO, E , CESARI, E , AMATO, MP , (2013) CURRENT RECOMMENDATIONS FOR MULTIPLE SCLEROSIS TREATMENT IN PREGNANCY AND PUERPERIUM.EXPERT REVIEW OF CLINICAL IMMUNOLOGY. VOL. 9. ISSUE 7. P. 683-692 | 48 | 96% | 7 |
5 | VOSKUHL, RR , GOLD, SM , (2012) SEX-RELATED FACTORS IN MULTIPLE SCLEROSIS SUSCEPTIBILITY AND PROGRESSION.NATURE REVIEWS NEUROLOGY. VOL. 8. ISSUE 5. P. 255-263 | 66 | 55% | 47 |
6 | GOLD, SM , VOSKUHL, RR , (2016) PREGNANCY AND MULTIPLE SCLEROSIS: FROM MOLECULAR MECHANISMS TO CLINICAL APPLICATION.SEMINARS IN IMMUNOPATHOLOGY. VOL. 38. ISSUE 6. P. 709 -718 | 50 | 69% | 1 |
7 | POZZILLI, C , PUGLIATTI, M , (2015) AN OVERVIEW OF PREGNANCY-RELATED ISSUES IN PATIENTS WITH MULTIPLE SCLEROSIS.EUROPEAN JOURNAL OF NEUROLOGY. VOL. 22. ISSUE . P. 34 -39 | 33 | 100% | 3 |
8 | MILLER, DH , FAZEKAS, F , MONTALBAN, X , REINGOLD, SC , TROJANO, M , (2014) PREGNANCY, SEX AND HORMONAL FACTORS IN MULTIPLE SCLEROSIS.MULTIPLE SCLEROSIS JOURNAL. VOL. 20. ISSUE 5. P. 527 -536 | 49 | 64% | 15 |
9 | COYLE, PK , (2012) PREGNANCY AND MULTIPLE SCLEROSIS.NEUROLOGIC CLINICS. VOL. 30. ISSUE 3. P. 877-+ | 48 | 74% | 6 |
10 | AMATO, MP , PORTACCIO, E , (2015) FERTILITY, PREGNANCY AND CHILDBIRTH IN PATIENTS WITH MULTIPLE SCLEROSIS: IMPACT OF DISEASE-MODIFYING DRUGS.CNS DRUGS. VOL. 29. ISSUE 3. P. 207 -220 | 55 | 50% | 6 |
Classes with closest relation at Level 1 |